Stay updated on Re-sensitizing Carboplatin-Resistant Ovarian Cancer: FAK Clinical Trial
Sign up to get notified when there's something new on the Re-sensitizing Carboplatin-Resistant Ovarian Cancer: FAK Clinical Trial page.

Latest updates to the Re-sensitizing Carboplatin-Resistant Ovarian Cancer: FAK Clinical Trial page
- Check7 days agoChange DetectedThe page footer now shows Revision: v3.6.2 instead of v3.6.0, reflecting a system update. This change does not modify the study content or user-facing information beyond the version label.SummaryDifference0.1%

- Check14 days agoChange DetectedA set of indexing terms, regulatory data flags, and page metadata were removed from the study page, reducing searchable keywords and labels while leaving the core study details accessible.SummaryDifference18%

- Check21 days agoChange DetectedAdds new quick-access sections for joining and contacting the study (Check who can join, How to Join a Study, Find Contact Information) and guidance pages (How to Read a Study Record, Common Questions), plus a site revision note (Revision: v3.6.0). Removes an older Interventions/Treatment heading with different formatting and trims out some topic tags (Ovarian cancer, MedlinePlus Genetics) to streamline the page.SummaryDifference0.6%

- Check28 days agoChange DetectedOvarian cancer is added as a related topic and MedlinePlus Genetics is listed under related topics. The page shows a new revision line: Revision: v3.5.5.SummaryDifference0.2%

- Check50 days agoChange DetectedA new revision tag Revision: v3.5.4 was added and the previous tag Revision: v3.5.3 was removed. This indicates an administrative update to the study record rather than a change to the study content.SummaryDifference0.1%

- Check64 days agoChange DetectedRemoved the related topics entries for 'Ovarian cancer' and 'MedlinePlus Genetics' from the page's related topics section. This changes the related-topic suggestions shown to users but does not affect the study data or eligibility.SummaryDifference0.2%

Stay in the know with updates to Re-sensitizing Carboplatin-Resistant Ovarian Cancer: FAK Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Re-sensitizing Carboplatin-Resistant Ovarian Cancer: FAK Clinical Trial page.